Nolato acquires Dutch Unitron – strengthens the total customer offering in the Medical Solutions business area; MedWorld Advisors serves as Sell-side advisor
Click here to view Nolato’s Press Release.
PRESS RELEASE
01 September 2026
West Palm Beach, FL – MedWorld Advisors, a global M&A advisory firm specializing in healthcare and MedTech, is pleased to announce the acquisition of its client, Unitron Group B.V., by Nolato AB. MedWorld Advisors served as the exclusive sell-side advisor to Unitron Group B.V., providing strategic guidance throughout the transaction process.
The combination strengthens Nolato’s Medical Solutions business by adding Unitron’s expertise in complex mechatronic and electronic medical devices to Nolato’s polymer-based development and manufacturing platform. Together, the companies broaden the capabilities available to healthcare and life-science customers — spanning device development, regulatory support, and scalable production from prototype to volume — and expand the combined group’s reach across the European, North American, and Japanese markets.
Unitron Group B.V., headquartered in IJzendijke, the Netherlands, develops and manufactures high-end life-science devices with more than 30 years of experience in complex mechatronic and electronic equipment. Its expertise spans fields including electrophysiology, optics, ventilation, anesthesia, ophthalmology, oncology, and diagnostics, and it produces more than 250 different products each year for medical customers worldwide. As a full-service partner certified to ISO 13485, Unitron manages the complete product lifecycle — from proof of concept and development through CE and FDA certification, MDR/IVDR regulatory support, production, and post-production logistics.
For Nolato, the acquisition aligns with its strategy to expand its Medical Solutions offering and add complementary device-development and manufacturing capabilities. By integrating Unitron’s expertise, Nolato aims to deliver greater value to healthcare and pharmaceutical customers and reinforce its position as a partner of choice in the sector.
MedWorld Advisors served as the exclusive sell-side advisor to Unitron Group B.V., guiding the company through the full transaction process. The engagement reflects MedWorld Advisors’ continued dedication to helping MedTech and healthcare companies achieve successful outcomes in the global M&A market — a reflection of the firm’s guiding principle that Value = Strategic Fit + Timing®.
About MedWorld Advisors
MedWorld Advisors is a global M&A advisory firm focused on healthcare and MedTech, serving founders, strategics, and investors on buy- and sell-side engagements. With a focus on the lower middle market, MedWorld Advisors partners with companies to navigate complex transactions, providing tailored strategies that drive value and achieve successful outcomes.
Contact Information:
MedWorld Advisors
Dave Sheppard, Co-Founder & Managing Director
davesheppard@medworldadvisors.com
+1 978 684-2712
Click here to view Nolato’s Press Release.
